Diagnostics Biochem Canada Inc.

Manufacturing Innovative IVD
for the World Since 1973

At Diagnostics Biochem Canada Inc. (DBC), it has been our mission for over 45 years to develop and market unique immunoassay kits that make a difference in the field of diagnostics and in public health. As a manufacturer of high quality immunoassays to a global market, we are constantly looking for new technologies and applications that can lead to an improvement in the diagnosis of disease and ultimately impact the quality of life for people around the world.

DBC News

New Anti-SARS-CoV-2 ELISA kits

DBC has received Health Canada COVID-19 Medical Device Authorization for the sale of its Anti-SARS-CoV-2 Total Antibody ELISA Kit and …

COVID-19 / Infectious Disease / News

Communiqué de Presse – Développement de tests ELISA pour la COVID-19

Aujourd’hui, Diagnostics Biochem Canada (DBC) annonce avoir développé des tests ELISA sérologiques pour la détermination des anticorps anti-COVID-19 dans le …

COVID-19 / Infectious Disease / News

Press Release – Developing ELISA test kits for COVID-19

Today, Diagnostics Biochem Canada (DBC) announced that they have developed ELISA test kits for the determination of anti-COVID-19 antibodies in …

ELISA kits / New kits / News

A New 17α-OHP ELISA kit

CAN-P-400 Comparison vs LCMS (n=40)DBC’s NEW 17α-OHP ELISA kit offers a number of exciting features, including: No Sample Preparation No …

products

Please browse our line of ELISA and LIA kits. If you do not see a product available which you are interested in or would like additional product information, please contact us.